Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-17

Clinical Trial Update: Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing levetiracetam to standard antiepileptic drugs (carbamazepine and valproate) as monotherapy in newly diagnosed epilepsy has completed. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEPAKOTE (DIVALPROEX SODIUM)
  • Keppra (levetiracetam)
  • TEGRETOL (CARBAMAZEPINE)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: COMPLETED